Riskpilot← Back to searchSign inGet full accessHIPPOMEDICA AB
ABActiveOrg 5591625198Borelund 551Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
SEK 390K
+76% vs 2023
EBITDA margin
38.2%
+1142% vs 2023
Equity ratio
60.5%
Financial strength
Net profit 2024
SEK 117K
+1200% vs 2023
| Revenue | SEK 390K | +76% |
| EBITDA | SEK 149K | +1142% |
| Net profit | SEK 117K | +1200% |
| Total assets | SEK 570K | +41% |
| Equity | SEK 345K | +51% |
| Employees | 0 | — |
Legal name
HIPPOMEDICA AB
Org number
5591625198
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är tredelad: Läkare- och fysioterapeutisk verksamhet samt konsult, instruktör, lärare, föreläsare och därmed förenlig verksamhet inom humanmedicin, rid- och hästsport och övrig idrott. Handel med antikviteter av olika typer, handel och tillverkning av hemslöjdsalster samt kapitalförvaltning och därmed förenlig verksamhet. Hästavel, stuteri och tävlingsverksamhet samt handel med hästar. Montering och inredning av stallbyggnader, tillverkning, renovering och försäljning av hästsportartiklar och därmed förenlig verksamhet samt marknadsföring.
Address
Borelund 551
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 280 | 320 | 223 | 222 | 390 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 131 | 111 | 42 | 12 | 149 |
| Depreciation & amort. | −60 | −50 | −50 | −40 | −0 |
| EBIT | 71 | 61 | −8 | −28 | 149 |
| Net financials | −2 | −2 | −2 | −1 | −2 |
| Profit before tax | 69 | 59 | 48 | 12 | 147 |
| Tax | −15 | −12 | −11 | −3 | −30 |
| Net profit | 54 | 47 | 37 | 9 | 117 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 364 | 344 | 368 | 403 | 570 |
| Equity | 135 | 182 | 219 | 228 | 345 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 131 | 64 | 109 | 174 | 224 |
| Total debt | 131 | 64 | 109 | 174 | 224 |
EBITDA margin
38.2%
This company
15.8%
Market median
+142% vs market
20202024
Equity ratio
60.5%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
33.9%
This company
18.4%
Market median
+84% vs market
20202024
Net profit margin
30.0%
This company
8.1%
Market median
+270% vs market
20202024
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20202024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HIPPOMEDICA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Gunnar Adils S G Hammargren | Chief Executive Officer | 0 companies |
| Kerstin Maria Arph Hammargren | Chairman | 0 companies |
| Karin Elisabeth T U Hammargren | Deputy Board Member | 0 companies |
| Sten Oskar Magnus U Hammargren | Deputy Board Member | 0 companies |